AzTrials
AzTrials

Metacarpal FractureNCT06210191

Intramedullary Headless Screw Fixation for Metacarpal and Phalangeal Fractures

A study testing Intramedullary headless screw fixation in people with Metacarpal Fracture and Phalanx Fracture, run by Assiut University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Intramedullary headless screw fixation for metacarpal and phalangeal fractures Read more about this study

Who is it for?
Ages 16 to 90 years
Conditions the study is for
Metacarpal Fracture, Phalanx Fracture
What is being tested?
Intramedullary headless screw fixation
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
35 participants
Where
1 siteEgypt
Study dates
Mar 2024to Mar 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 90 years
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Skeletally mature patients with closed fractures of phalanges and metacarpals.
  • Patients with open type I fractures of phalanges and metacarpals.

Who cannot join

  • Skeletally immature patients with open physis.
  • Patients with open type II or III fractures of phalanges or metacarpals.
  • Patients with fractures of phalanges or metacarpals with neurovascular injury. 4 Patients with associated tendon injuries.

Trial locations and contacts

1 site in 1 country.

Ahmed Megahed, resident contact

+201007712309

megahed117@gmail.com

Egypt1 site
  • Faculty of medicine

    Asyut, 71515

    Waleed Riad, professor, +201142123037, Drwaleedriad@gmail.com

Other trials in Egypt

About this study

Intramedullary headless screw fixation for metacarpal and phalangeal fractures

Read the detailed description

The most frequent fractures in the upper extremities are phalangeal and metacarpal fractures accounts about 40%, which follow distal radius fractures in order of frequency.

There are many methods of fixation of these fractures as plates and K-wires. Plate fixation is able to provide open reduction and stability for early range of motion with mixed clinical results. Reported complications include stiffness, fixed flexion contracture of the adjacent joints, soft tissue dissection, and extensor lag.

There are minimally invasive techniques, including the use of K-wires, lag screws, cerclage wiring, and external fixation that limit soft tissue dissection. These options have drawbacks of malunion, nonunion, infection, need for hardware removal, and stiffness.

Intramedullary headless screw fixation is an emerging alternative to K-wire or plate fixation of displaced and unstable fractures of the phalanges and metacarpals. The Intramedullary headless screw fixation is a new option that offers rigid stability, early active range of motion, and easy insertion. Due to the minimally invasive nature of this technique, patients will experience better results in terms of range of motion, return to work faster, and minimize complications.

Beck et al. reported 100% of patients achieved full radiological union with minor complication rate and full range of motion and early return to work with average 96% of grip strength.

Being tested
Intramedullary headless screw fixation
Keywords
intramedullary headless screw fixation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intramedullary headless screw fixationProcedure or surgery

    fixation of fractures of metacarpals and phalanges by intramedullary headless screws

Study groups in NCT06210191
Study groupRoleWhat they receive
union of fractureExperimentalIntramedullary headless screw fixation for metacarpal and phalangeal fractures
Receives: Procedure: Intramedullary headless screw fixation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Achieve full range of motion of hand joints

    Change DASH Score of hand functions to 0 by this intervention. As 0 is excellent and 100 is the worst outcome

    Measured: 6 weeks for active range of motion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jan 2024
  2. Study startMar 2024 (estimated)
  3. Primary completionMar 2025 (estimated)
  4. Study completionMar 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
35 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06210191
Sponsor's protocol ID
Intramedullary screw fixation
Status last verified
Feb 2024
First submitted
18 Dec 2023
Last updated
9 Feb 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: There is a plan to make IPD and related data dictionaries available. all collected IPD, all IPD that underlie results in a publication)

Questions about this trial

What is this clinical trial studying?

A study testing Intramedullary headless screw fixation in people with Metacarpal Fracture and Phalanx Fracture, run by Assiut University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ahmed Megahed, resident (+201007712309, megahed117@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Achieve full range of motion of hand joints (time frame: 6 weeks for active range of motion). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in